Inosine pranobex

This classification denotes an immunostimulant with the molecular formula C10H12N4O5.3C9H9NO3.3C5H13NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W1SO0V223F, chemically known as p-acetamidobenzoic salt of n,n-dimethylamino-2-propanol & inosine (3:1) np 113 but generally known as inosine pranobex, which bears US NIH Compound Identifier 37510. European Medicines Agency schedules Inosine pranobex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14214MIG. World Health Organization schedules inosine pranobex in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule inosine pranobex under HS 29349990 and SITC 51579. As of Q4 2014, INOSINE PRANOBEX remains the US FDA Preferred Term for this commodity. Inosine pranobex bears US NLM identifiers UMLS ID C0022230 and NCI Concept Code C601. SMILES: CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-].CC(CN(C)C)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.C1=NC(=O)C2=C(N1)N(C=N2)C3C(C(C(O3)CO)O)O.